[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $genff Crypto project sees positive social sentiment. Market volatility causes price fluctuations. ### About $genff A cryptocurrency project. ### Engagements: X [#](/topic/$genff/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$genff/time-series/interactions.tsv) **Current Value**: X **Daily Average**: XX **1-Year High**: XX on 2025-07-27 **1-Year Low**: X on 2025-10-16 | Social Network | X | | -------------- | - | | Engagements | X | ### Mentions: X [#](/topic/$genff/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$genff/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1-Year High**: X on 2025-07-27 **1-Year Low**: X on 2025-10-13 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$genff/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$genff/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $genff in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1-Year High**: X on 2025-07-27 **1-Year Low**: X on 2025-10-13 ### Sentiment: % [#](/topic/$genff/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$genff/time-series/sentiment.tsv) **Current Value**: % **Daily Average**: XXX% **1-Year High**: XXX% on 2025-07-27 **1-Year Low**: XXX% on 2025-07-27 **Top topics mentioned** In the posts about $genff in the last XX hours [aged](/topic/aged), [october 2025](/topic/october-2025) ### Top Social Posts [#](/topic/$genff/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$GENFF Genflow Biosciences Announces Update on Dog Aging Program Genflow Biosciences provided an update on its Dog Aging (GF-1004) proof-of-concept trial testing a centenarian SIRT6 gene therapy in elderly dogs. Repeat administration was completed in October 2025 in the randomized controlled study of XX beagles aged 10+ with no ill or adverse effects observed after the second dosing. The dogs enter a follow-up period expected to conclude in January 2026. The company highlighted potential animal-health commercial opportunities and continued partnership development while advancing to next-stage" [X Link](https://x.com/MarcJacksonLA/status/1976543103361351995) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-10T06:59Z 7574 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Crypto project sees positive social sentiment. Market volatility causes price fluctuations.
A cryptocurrency project.
Engagements 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
1-Year High: XX on 2025-07-27
1-Year Low: X on 2025-10-16
Social Network | X |
---|---|
Engagements | X |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-07-27
1-Year Low: X on 2025-10-13
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $genff in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1-Year High: X on 2025-07-27
1-Year Low: X on 2025-10-13
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: XXX%
1-Year High: XXX% on 2025-07-27
1-Year Low: XXX% on 2025-07-27
Top topics mentioned In the posts about $genff in the last XX hours
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$GENFF Genflow Biosciences Announces Update on Dog Aging Program Genflow Biosciences provided an update on its Dog Aging (GF-1004) proof-of-concept trial testing a centenarian SIRT6 gene therapy in elderly dogs. Repeat administration was completed in October 2025 in the randomized controlled study of XX beagles aged 10+ with no ill or adverse effects observed after the second dosing. The dogs enter a follow-up period expected to conclude in January 2026. The company highlighted potential animal-health commercial opportunities and continued partnership development while advancing to next-stage"
X Link @MarcJacksonLA 2025-10-10T06:59Z 7574 followers, XXX engagements
/topic/$genff